Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

Cited by (1,001)

Items 601–700 of 1,001

  1. The Role of Regulatory T Cells in Cancer Treatment Resistance
    Anna Dąbrowska, Magdalena Grubba, Amar Balihodzic, Olga Szot, Bartosz Kamil Sobocki, Adrian Perdyan · 2023 · International Journal of Molecular Sciences
  2. Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal
    Alexander Batista-Duharte, Damiana Téllez-Martínez, Deivys Leandro Portuondo, Iracilda Zeppone Carlos · 2017 · Pharmacological Research
  3. Salidroside regulates tumor microenvironment of non-small cell lung cancer via Hsp70/Stub1/Foxp3 pathway in Tregs
    Zexin Wen, Ying Liu, Yanli Zhang, Qiujuan Yue, Hang Meng, Yijie He, Yi Yang, Minghao Li, Jianwen Zheng, Wei Lin · 2023 · BMC Cancer
  4. Engineering customized nanovaccines for enhanced cancer immunotherapy
    JinYu Guo, Changhua Liu, Zhaoyang Qi, Ting Qiu, Jin Chi Zhang, Huanghao Yang · 2024 · Bioactive Materials
  5. FGL1 and FGL2: emerging regulators of liver health and disease
    Jiongming Chen, Lei Wu, Yongsheng Li · 2024 · Biomarker Research
  6. Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
    Yuli Ge, Qiong Zhou, Fan Pan, Rui Wang · 2025 · International Journal of Nanomedicine
  7. Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions
    Young Kwang Chae, Michael S. Oh, Francis Joseph Giles · 2017 · The Oncologist
  8. Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology
    Nicolás A. Giraldo, J. David Peske, Catherine Sautès‐Fridman, Wolf H. Fridman · 2019 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  9. Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma.
    S. Mutsaers, F. Pixley, C. Prêle, G. Hoyne · 2020 · Current Opinion in Immunology
  10. Adoptive transfer of Tregs: A novel strategy for cell-based immunotherapy in spontaneous abortion: Lessons from experimental models
    Sassan Mohammadi, Elham Abdollahi, Maria Nezamnia, Seyed‐Alireza Esmaeili, Fataneh Tavasolian, Thozhukat Sathyapalan, Amirhossein Sahebkar · 2020 · International Immunopharmacology
  11. Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation
    Marcus Bergström, Ming Han Yao, Malin Müller, Olle Korsgren, Bengt von Zur‐Mühlen, Torbjörn Lundgren · 2021 · Transplant International
  12. The role of myeloid-derived suppressor cells in liver cancer
    Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang, Yuling Qiu · 2023 · Discover Oncology
  13. Tumor microenvironment crosstalk between tumors and the nervous system in pancreatic cancer: Molecular mechanisms and clinical perspectives
    Wenchao Xu, Jianzhou Liu, Jianlu Zhang, Jun Lu, Junchao Guo · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  14. Anti-stromal nanotherapeutics for hepatocellular carcinoma
    Zhuo Yu, Leaf Huang, Jianfeng Guo · 2024 · Journal of Controlled Release
  15. Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin
    Jeff Xiwu Zhou, Xiao-Yan Yang, Shunbin Ning, Ling Wang, Kesheng Wang, Yanbin Zhang, Fenghua Yuan, Fengli Li, David D. Zhuo, Liren Tang et al. · 2017 · Oncotarget
  16. Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK -positive non-small-cell lung cancer
    Kyoung‐Ho Pyo, Sun Min Lim, Chae-Won Park, Ha-Ni Jo, Jae Hwan Kim, Miran Yun, Do‐Hee Kim, Chun-Feng Xin, Wongeun Lee, Bianca-Ioana Gheorghiu et al. · 2020 · Journal for ImmunoTherapy of Cancer
  17. A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer
    Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E. Bender, Ilgen Mender, Victor Stastny, Benjamin Jacob Drapkin et al. · 2024 · Nature Communications
  18. Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy
    Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern, Paul D. Kirchhoff, Rakesh Nagilla, Larry J. Jolivette, Cory Rice et al. · 2025 · Nature Communications
  19. Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy
    Hao Zheng, Yiquan Chen, Wei Luo, Shiqi Han, Mengjuan Sun, Lin Min, Cheng-Han Wu, Lili Gao, Tian Xie, Na Kong · 2025 · Journal of Nanobiotechnology
  20. Peptide-targeted nanoparticles for tumor therapy
    Valeria Sidorenko, Allan Tobi, Kazuki N. Sugahara, Tambet Teesalu · 2025 · Journal of Controlled Release
  21. The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients
    Moshira Ezzat Saleh, Ramy Gadalla, Hebatallah Hassan, Ahmed Afifi, Martin Götte, Mohamed El‐Shinawi, Mona Mostafa Mohamed, Sherif Ibrahim · 2019 · PLoS ONE
  22. Helper T cells in malignant pleural effusion
    Feng‐Shuang Yi, Kan Zhai, Huan‐Zhong Shi · 2020 · Cancer Letters
  23. A user's guide to multicolor flow cytometry panels for comprehensive immune profiling
    Staffan Holmberg-Thydén, Kirsten Grønbæk, Anne Ortved Gang, Daniel El Fassi, Sine Reker Hadrup · 2021 · Analytical Biochemistry
  24. Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment
    Lingling Jiang, Haiyi Fei, Anran Yang, Jiajuan Zhu, Jindan Sun, Xiu Liu, Wenzhi Xu, Jianhua Yang, Songying Zhang · 2021 · Cancer Letters
  25. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer
    Xuejiao Li, Huan Du, Shenghua Zhan, Wenting Liu, Zhangyu Wang, Jing Quan Lan, Longxiang PuYang, Yuqiu Wan, Qiu‐Xia Qu, Sining Wang et al. · 2022 · Frontiers in Immunology
  26. Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients
    Jinren Zhou, Qing Shao, Yunjie Lu, Yu Li, Zibo Xu, Bo Zhou, Qiuyang Chen, Xiangyu Li, Xiaozhang Xu, Yufeng Pan et al. · 2022 · Frontiers in Oncology
  27. Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis
    Chunbo Li, Danyang Liu, Shimin Yang, Keqin Hua · 2022 · Frontiers in Immunology
  28. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells
    Salma A. Al Shamma, Dana M. Zaher, Fatema Hersi, Nour N. Abu Jayab, Hany A. Omar · 2023 · Life Sciences
  29. The potential of regulatory T cell-based therapies for alopecia areata
    Sheng Wan, Wen Xu, Bo Xie, Cuiping Guan, Xiuzu Song · 2023 · Frontiers in Immunology
  30. Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg
    Nianqiu Liu, Bin Liu, Li Zhang, Hu Li, Zhiwei Chen, Aoran Luo, Min Chen, Mingli Peng, Wenwei Yin, Hong Ren et al. · 2018 · International Immunopharmacology
  31. Cellular immunotherapy for acute myeloid leukemia: How specific should it be?
    Jong Bok Lee, Branson Chen, Daniel Vasić, Arjun Law, Zhang Li · 2019 · Blood Reviews
  32. Role of heterogeneous regulatory T cells in the tumor microenvironment
    Ting Wei, Weijie Zhong, Qingshan Li · 2020 · Pharmacological Research
  33. Identification of shared characteristics in tumor-infiltrating T cells across 15 cancers
    Xiyun Jin, Yideng Cai, Guangfu Xue, Jinhao Que, Rui Cheng, Yuexin Yang, Lixing Xiao, Xiaoyu Lin, Chang Xu, Pingping Wang et al. · 2023 · Molecular Therapy — Nucleic Acids
  34. Identifying mitophagy-related genes as prognostic biomarkers and therapeutic targets of gastric carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data
    Zehua Wang, Chen Chen, Jiaoyu Ai, Jiao Shu, Yi Ding, Wenjia Wang, Yaping Gao, Yongxu Jia, Yanru Qin · 2023 · Computers in Biology and Medicine
  35. Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies
    Reona Leo Sakemura, Michelle J. Cox, Mehrdad Hefazi, Elizabeth L. Siegler, Saad S. Kenderian · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  36. The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
    Guirong Liu, Manman Liu, Junjuan Wang, Yao Mou, Huilian Che · 2021 · Frontiers in Immunology
  37. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
    Liang Wang, Xiangwei Ge, Zifeng Zhang, Ya-Ting Ye, Ziyi Zhou, Manhong Li, Hongxiang Yan, Lei Wu, Qian Bai, Jipeng Li et al. · 2021 · Frontiers in Genetics
  38. The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
    Yue Guo, Yin Liu, Wei Zhang, Heng Luo, Ping Shu, Guofang Chen, Yuping Li · 2022 · Discover Oncology
  39. Pregnancy and Tumour: The Parallels and Differences in Regulatory T Cells
    Prerana Muralidhara, Vanshika Sood, Vishnu Vinayak Ashok, Kushagra Bansal · 2022 · Frontiers in Immunology
  40. Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma
    Lei Xu, Yun Lü, Zhengdong Deng, Xiangyu Li, Yuanxin Shi, Kai Zhao, Wei Yao, Jianming Wang · 2022 · Journal of Translational Medicine
  41. Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
    Sara Lecomte, Julien Devreux, Grégoire de Streel, Nicolas van Baren, Violaine Havelange, David Schröder, Noora Vaherto, Christophe Vanhaver, Christophe Vanderaa, Noémie Dupuis et al. · 2022 · Blood
  42. Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
    Jiexi Wen, Jie Zeng, Catherine Liu, Abdol Aziz Ould Ismail, Weijie Ma · 2024 · International Journal of Molecular Sciences
  43. Precise Spatiotemporal Interruption of Regulatory T-cell–Mediated CD8+ T-cell Suppression Leads to Tumor Immunity
    Xiaoyu Zhou, Shushu Zhao, Yue He, Shuang Geng, Yan Shi, Bin Wang · 2018 · Cancer Research
  44. Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
    Tao Dao, Sung Soo Mun, Andrew Scott, Casey A. Jarvis, Tatyana Korontsvit, Zhiyuan Yang, Lianxing Liu, Martin G. Klatt, Manuel Guerreiro, Annamalai Selvakumar et al. · 2019 · OncoImmunology
  45. Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
    Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Sven Utikal, Viktor Umansky · 2023 · OncoImmunology
  46. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
    Huang-Zhen Xu, Xinyi Lin, Yunxian Xu, Huibin Xue, Shu Lin, Tianwen Xu · 2023 · Frontiers in Immunology
  47. Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons
    Yifeng Wang, Shengguang Ding · 2024 · Journal of Translational Medicine
  48. Nanotechnology for boosting ovarian cancer immunotherapy
    Prabhjot Kaur, Santosh Kumar Singh, Manoj Kumar Mishra, Shailesh Singh, Rajesh Singh · 2024 · Journal of Ovarian Research
  49. CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor
    Ishita Sarkar, Debashree Basak, Puspendu Ghosh, Anupam Gautam, Arpita Bhoumik, Praveen Singh, Anwesha Kar, Shaun Mahanti, Snehanshu Chowdhury, Lagnajita Chakraborty et al. · 2025 · Science Advances
  50. Distinct Expression of Coinhibitory Molecules on Alveolar T Cells in Patients With Rheumatoid Arthritis–Associated and Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease
    Maho Nakazawa, Katsuya Suzuki, Masaru Takeshita, Jun Inamo, Hirofumi Kamata, Makoto Ishii, Yoshitaka Oyamada, Hisaji Oshima, Tsutomu Takeuchi · 2020 · Arthritis & Rheumatology
  51. Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?
    Enrico Maggi, Irene Veneziani, Lorenzo Moretta, Lorenzo Cosmi, Francesco Annunziato · 2020 · Cancers
  52. Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
    Lena Gaissmaier, Petros Christopoulos · 2020 · Respiration
  53. Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma
    Jaime L. Chao, Michael Korzinkin, A. Zhavoronkov, I. Ozerov, M. Walker, Kathleen E. Higgins, M. Lingen, E. Izumchenko, Peter A Savage · 2021 · Cell Reports Medicine
  54. Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
    Marie Roelens, Adèle de Masson, Anaïs Andrillon, Caroline Ram‐Wolff, Lucie Biard, Marie Boisson, Samia Mourah, Maxime Battistella, Antoine Toubert, Martine Bagot et al. · 2022 · British Journal of Dermatology
  55. Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
    Tynisha S. Rafael, Jossie Rotman, Oscar Roberto Brouwer, Henk G. van der Poel, Constantijne Helene Mom, Gemma G. Kenter, Tanja D. de Gruijl, Ekaterina S. Jordanova · 2022 · Journal of Clinical Medicine
  56. Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
    Zilan Ye, Dongqiang Zeng, Rui Zhou, Min Shi, Wangjun Liao · 2022 · Frontiers in Immunology
  57. Multivalent, Bispecific αB7-H3-αCD3 Chemically Self-Assembled Nanorings Direct Potent T Cell Responses against Medulloblastoma
    Ellie A. Mews, Pauline J. Beckmann, Mahathi Patchava, Yiao Wang, David A. Largaespada, Carston R. Wagner · 2022 · ACS Nano
  58. Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy
    Junjie Liu, Haisu Tao, Tong Yuan, Jiang Li, Jian Li, Huifang Liang, Zhiyong Huang, Erlei Zhang · 2022 · Frontiers in Immunology
  59. Colorectal Cancer and Purinergic Signalling: An Overview
    Gabriela Gonçalves Roliano, Juliana H. Azambuja, Veronica Brunetto, Hannah E. Butterfield, Antônio Nocchi Kalil, Elizandra Braganhol · 2022 · Cancers
  60. Association of gallstone disease with risk of colorectal cancer: a systematic review and meta-analysis of observational studies
    Georgios Polychronidis, Haziq Siddiqi, Fasih Ali Ahmed, Stefania Papatheodorou, Edward L. Giovannucci, Mingyang Song · 2023 · International Journal of Epidemiology
  61. Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
    Anne E. O’Shea, Guy Travis Clifton, Na Qiao, Brandy M. Heckman‐Stoddard, Malgorzata E. Wojtowicz, Eileen P. Dimond, Isabelle Bedrosian, Diane M. Weber, Judy Ellen Garber, Alexander Husband et al. · 2023 · Cancer Prevention Research
  62. Schottky Heterojunction Realizes In Situ Vaccine‐Like Antitumor Efficacy and Microenvironment Remodeling Upon Near‐Infrared Laser Response in Cold Tumors
    Xueru Song, Xiaoyu Zhou, Yunfeng Pan, Kaijie Liang, Yuting Luo, Wanrong Xie, Zhongyang Lv, Dingyi Yang, Yong Wang, Xiaoshan Wu et al. · 2023 · Advanced Functional Materials
  63. Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment
    Magdalena Strachowska, Agnieszka Robaszkiewicz · 2024 · Pharmacology & Therapeutics
  64. Epstein–Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells
    Tomonori Higuchi, Kazuhiko Matsuo, Yumiko Hashida, Kosuke Kitahata, Takako Ujihara, Ayuko Taniguchi, Osamu Yoshie, Takashi Nakayama, Masanori Daibata · 2019 · Cancer Letters
  65. PD-1-stimulated T cell subsets are transcriptionally and functionally distinct
    Lerrer, Shalom, Tocheva, Anna S., Bukhari, Shoiab, Adam, Kieran, Mor, Adam · 2021 · iScience
  66. Mechanism of Action of Lactic Acid on Histones in Cancer
    Riccardo Sgarra, Sabrina Battista, Laura Cerchia, Guidalberto Manfioletti, Monica Fedele · 2023 · Antioxidants and Redox Signaling
  67. T cell-mediated mechanisms of immune-related adverse events induced by immune checkpoint inhibitors
    Lintong Li, Yunfan Huang, Ruzeng Xue, Li Li, Li Li, Liuping Liang, Kuan Lai, Xiaowen Huang, Yao Qin, Yue Zheng · 2025 · Critical Reviews in Oncology/Hematology
  68. Ubiquitination in cancer: mechanisms and therapeutic opportunities
    Susi Zhu, Xu Zhang, Waner Liu, Zhe Guang Zhou, Siyu Xiong, Jie Li, Xiang Chen, Cong Peng · 2025 · 癌症:英文版
  69. Results From a First‐in‐Human Study of BNZ‐1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines
    Paul Frohna, Anoshie Ratnayake, Nicholas Doerr, Asjad Basheer, Laith Q. Al‐Mawsawi, Woo Jae Kim, Juan Carlos Zapata, Xiaorong Wu, Thomas A. Waldmann, Nazli Azimi et al. · 2019 · The Journal of Clinical Pharmacology
  70. Galunisertib Drives Treg Fragility and Promotes Dendritic Cell-Mediated Immunity against Experimental Lymphoma
    Sumit Kumar Hira, Abhinandan Rej, Ankush Paladhi, Ranjeet Kumar Singh, Jayasree Saha, Indrani Mondal, Sankar Bhattacharyya, Partha Pratim Manna · 2020 · iScience
  71. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model
    Ifeanyi Kingsley Uche, Natalie Wall Fowlkes, Luan D. Vu, Tatiane Terumi Negrão Watanabe, Mariano Carossino, Rafiq Nabi, Fábio Del Piero, Jared S. Rudd, Konstantin Gus Kousoulas, Paul J. F. Rider · 2020 · Journal of Virology
  72. Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells
    K. Satoh, Yoichi Kobayashi, Kaori Fujimaki, Shinko Hayashi, Saori Ishida, Daisuke Sugiyama, Takahiko Sato, Kyungtaek Lim, Megumi Miyamoto, Shiho Kozuma et al. · 2021 · International Immunology
  73. Lineage Reprogramming of Effector Regulatory T Cells in Cancer
    Michael L. Dixon, Jonathan D. Leavenworth, Jianmei W. Leavenworth · 2021 · Frontiers in Immunology
  74. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
    Xiaofan Jiang, Lu Liang, Guanglei Chen, Caigang Liu · 2021 · Cells
  75. A dendritic cell-like biomimetic nanoparticle enhances T cell activation for breast cancer immunotherapy
    Yanhua Li, Kun Tang, Xia Zhang, Wei Pan, Na Li, Bo Tang · 2021 · Chemical Science
  76. Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands
    Bratislav M. Janjic, Aditi Kulkarni, Robert Louis Ferris, Lazar N. Vujanovic, Nikola L. Vujanović · 2022 · Frontiers in Immunology
  77. Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Yukari Kobayashi, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi, Kosei Hasegawa · 2022 · BMC Cancer
  78. Steroid nuclear receptor coactivator 2 controls immune tolerance by promoting induced T reg differentiation via up-regulating Nr4a2
    Wencan Zhang, Xu Cao, Xiancai Zhong, Hongmin Wu, Mingye Feng, Yousang Gwack, Noah Isakov, Zuoming Sun · 2022 · Science Advances
  79. The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
    Young Min Son, Jihwan Kim · 2022 · Journal of Microbiology and Biotechnology
  80. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy
    Qianhong Su, Zuwei Liu, Ruolin Du, Xiaolu Chen, Longlong Chen, Zhaoming Fu, Xingyu Luo, Yong Yang, Xuequn Shi · 2023 · Acta Biomaterialia
  81. Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis
    Chao Sun, Guoji Zhu, Conghuan Shen, Shungen Huang, Ruidong Li, Jianhua Li, Zhenyu Ma, Zhengxin Wang · 2023 · Frontiers in Oncology
  82. AMPKα2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma
    Yan Ouyang, Yan Gu, Xinhai Zhang, Ya Huang, Xianpeng Wei, Fuzhou Tang, Shichao Zhang · 2024 · BMC Cancer
  83. Ectonucleotidase CD39 expression in regional metastases in head and neck cancer
    Magis Mandapathil, Mehtap Boduc, Marion Roeßler, Christian Güldner, Ute Walliczek‐Dworschak, Robert Mandić · 2017 · Acta Oto-Laryngologica
  84. Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix
    Mark Owyong, Gizem Efe, Michael Owyong, Aamna J. Abbasi, Vaishnavi Sitarama, Vicki Plaks · 2018 · Frontiers in Cell and Developmental Biology
  85. The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer
    N Karin, Hila Razon · 2018 · Cancer Immunology Immunotherapy
  86. Memory NK Cell Features Exploitable in Anticancer Immunotherapy
    Cristina Capuano, Chiara Pighi, Simone Battella, Angela Santoni, Gabriella Palmieri, Ricciarda Galandrini · 2019 · Journal of Immunology Research
  87. Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
    Marta Gascón Ruiz, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Pimienta Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez-Labrada, Andrea Sesma, Irene Torres-Ramón et al. · 2020 · Cells
  88. Berberine Protects against Hepatocellular Carcinoma Progression by Regulating Intrahepatic T Cell Heterogeneity
    Jiaxiang Hu, Qingmiao Shi, Xue Chen, Qingqing Wang · 2024 · Advanced Science
  89. Epithelial–Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges
    Yunyao Ye, Shanxun Yu, Ting Guo, Sihui Zhang, Xiaozhou Shen, Gaohua Han · 2024 · Biomolecules
  90. Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
    Kang Liu, Yue Li, Minmin Shen, Wei Xu, Shanshan Wu, Xinxin Yang, Bo Zhang, Nengming Lin · 2025 · Biomolecules
  91. Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment
    Qi An, Li Duan, Yuanyuan Wang, Fuxin Wang, Xiang Liu, Chao Liu, Qinyong Hu · 2025 · Journal of Translational Medicine
  92. Histone lactylation bridges metabolic reprogramming with chromatin-immune crosstalk in triple-negative breast cancer
    Jingyuan Li, Ziyi Li, Hao Zhang, Hao Zhang, Yao Tang, Yao Tang, Shimeng Guo, Ting Ye, Jianyu Wang, Jingyu Li · 2025 · Cancer Letters
  93. Expression of PD-L1 in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression
    Rafael Maciel Grochot, Janaína Brollo, Floriano Riva Neto, Aline C. Tregnago, Cassiano Scholze, Rui Norris, Sargeele Silva, Débora Cristina Weschenfelder, André Borba Reiriz, Lessandra Michelin et al. · 2019 · Cancer Management and Research
  94. Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer
    Jiaxing Sun, Jing Zhang, Haiyan Hu, Huan Qin, Ximing Liao, Feilong Wang, Wei Zhang, Qi Yin, Xiaoping Su, Yanan He et al. · 2021 · Journal of Cancer Research and Clinical Oncology
  95. Immunotherapeutic targets in non‐small cell lung cancer
    Habib Sadeghirad, Tayyeb Bahrami, Sepideh Mehrpour Layeghi, Hassan Yousefi, Meysam Rezaei, Seyed Reza Hosseini‐Fard, Payar Radfar, Majid Ebrahimi Warkiani, Kenneth John O'Byrne, Arutha Kulasinghe · 2022 · Immunology
  96. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
    Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, Konstantin Schnell, David Anz, Laura Hahn, Sarah Meister, Elisa Schmoeckel, Alexander Burges, Bastian Czogalla et al. · 2022 · Cellular Oncology
  97. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis reveals diagnostic and prognostic signatures and immunoinfiltration in gastric cancer
    Yiyan Zhai, Jingyuan Zhang, Zhihong Huang, Rui Shi, Fengying Guo, Fanqin Zhang, Meilin Chen, Yifei Gao, Xiaoyu Tao, Zhengsen Jin et al. · 2023 · Computers in Biology and Medicine
  98. Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis
    Jiaxin Liao, Yuqing Zhang, Min-Ying Huang, Zhijun Liang, Yao Gong, Ben Liu, Yuling Li, Jiaxi Chen, Wei Wu, Zunnan Huang et al. · 2023 · Bioorganic Chemistry
  99. CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Shuna Liu, Ziqi Tao, Jianfang Lou, Rong Li, Xin Fu, Juan Xu, Ting Wang, Lei Zhang, Wenwen Shang, Yepeng Mao et al. · 2023 · Journal of Translational Medicine
  100. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma
    Fengzeng Sun, Miaomiao Liao, Zi Tao, Ruiqi Hu, Jun Qin, Weiwei Tao, Wentong Liu, Yiqi Wang, Guoliang Pi, Junrong Lei et al. · 2024 · Journal of Cancer